Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
1 study found for:    19731330 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed Hydroxyurea to Prevent Organ Damage in Children With Sickle Cell Anemia
Conditions: Hematologic Diseases;   Anemia, Sickle Cell
Interventions: Drug: Hydroxyurea;   Drug: Placebo
To Top

† Indicates status has not been verified in more than two years